Back
Serina Therapeutics, Inc. Stock Predictions
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
4
SER
Serina Therapeutics, Inc.
Last Price:
$2.63
Seasonality Move:
-2.18%
7 Day Trial
ALL ACCESS PASS
$
7
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiSerina Therapeutics, Inc. Stock Forecast
-
Is Serina Therapeutics, Inc. Stock Undervalued?The current Serina Therapeutics, Inc. [SER] share price is $2.66. The Score for SER is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
-
SER is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Serina Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Serina Therapeutics, Inc. Stock Rating
Data Unavailable
Serina Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
serinatherapeutics.com
52-Week Data
52-Week High:
7.92
52-Week Low:
2.66
Prediction Charts
Market Cap:
28.3M
Price in USD:
2.66
Volume:
14.2K
Beta:
1.29
Technical Analysis
SMA50:
4.16
SMA100:
4.69
SMA200:
5.08
52-Wk Change:
-56.66%
Stock Predictions
-
Is Serina Therapeutics, Inc. stock public?Yes, Serina Therapeutics, Inc. is a publicly traded company.
-
What is the Serina Therapeutics, Inc. stock quote today?The Serina Therapeutics, Inc. stock price is 2.66 USD today.
-
How to buy Serina Therapeutics, Inc. stock online?You can buy Serina Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-1 | 4.04 | 3.90 | 4.20 | 3.90 |
| Dec-2 | 3.94 | 3.81 | 3.99 | 3.81 |
| Dec-3 | 3.70 | 3.48 | 3.79 | 3.47 |
| Dec-4 | 3.47 | 3.47 | 3.55 | 3.32 |
| Dec-5 | 3.53 | 3.25 | 3.53 | 3.23 |
| Dec-8 | 3.20 | 3.32 | 3.46 | 3.20 |
| Dec-9 | 3.20 | 3.31 | 3.38 | 3.15 |
| Dec-10 | 3.28 | 3.21 | 3.35 | 3.21 |
| Dec-11 | 3.34 | 3.14 | 3.34 | 3.14 |
| Dec-12 | 3.24 | 3.12 | 3.29 | 3.12 |
| Dec-15 | 3.15 | 2.99 | 3.15 | 2.95 |
| Dec-16 | 2.95 | 2.92 | 3.03 | 2.90 |
| Dec-17 | 2.99 | 2.94 | 2.99 | 2.84 |
| Dec-18 | 2.90 | 2.66 | 2.90 | 2.66 |
Serina Therapeutics, Inc. Earnings
Data Unavailable
Serina Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.37 per share, and an increase next year of $0.33 per share.
* Serina Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.